SCHEMBL7524003

SCHEMBL7524003

CC(=O)NN1C(=O)CCC(O)C1=O.c1cc2cc-2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
GAA P10253 1/20 0.33
DHODH Q02127 2/20 0.32
P2RX7 Q99572 4/20 0.32
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
LMNA P02545 1/20 0.31
PRKDC P78527 1/20 0.31
HCRTR1 O43613 1/20 0.31
HCRTR2 O43614 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4827396 0.80 GAA (0.43) NPC1RAB9AL3MBTL1KDM4EALDH1A1
SCHEMBL10545379 0.71 MEN1 (0.40) NPC1RAB9AL3MBTL1KDM4EALDH1A1
SCHEMBL10884861 0.69 ALDH1A1 (0.35) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL10389178 0.68 ALDH1A1 (0.35) NPC1RAB9AL3MBTL1KDM4EALDH1A1
SCHEMBL8014019 0.68 KDM4E (0.38) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL8019417 0.68 KDM4E (0.38) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL8883410 0.67 KDM4E (0.38) RAB9AKDM4EALDH1A1POLBDHODH
SCHEMBL4259463 0.67 LMNA (0.33) P2RX7LMNAHCRTR1HCRTR2KMT2A
SCHEMBL16327606 0.66 L3MBTL1 (0.47) NPC1RAB9AL3MBTL1KDM4EALDH1A1
SCHEMBL10890403 0.66 BRD4 (0.36) RAB9AKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020064790-A1 Design of drugs involving receptor-ligand-DNA interactions HENDRY LAWRENCE B (US) 2002-05-30 US disclosed
EP-0740708-A4 DESIGN OF DRUGS INVOLVING RECEPTOR-LIGAND-DNA INTERACTIONS HENDRY LAWRENCE B (US) 1999-12-01 EP disclosed
EP-0740708-A1 DESIGN OF DRUGS INVOLVING RECEPTOR-LIGAND-DNA INTERACTIONS Hendry, Lawrence B. (US) 1996-11-06 EP disclosed
WO-1995014791-A1 DESIGN OF DRUGS INVOLVING RECEPTOR-LIGAND-DNA INTERACTIONS HENDRY LAWRENCE B (US) 1995-06-01 WO disclosed